Method for processing hazardous inorganic waste for its neutralization

PL250127B1Active Publication Date: 2026-08-24GDANSKI UNIV MEDYCZNY

View PDF 2 Cites 0 Cited by

Patent Information

Application Number: PL2024448311
Authority / Receiving Office: PL · PL
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2024-04-16
Publication Date: 2026-08-24
Estimated Expiration: 2044-04-16

Application Information

Patent Timeline

16 Apr 2024

Application

PL2024448311

24 Aug 2026

Publication

PL250127B1

IPC: A61K39/395; A61P35/00; C07K16/18

CPC: C07K16/18; A61P35/02; C07K2317/72; C07K2317/734; A61K39/395; A61P35/00; A61K2039/505

Inventors: BUDKA DARIA; OKRÓJ MARCIN

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The subject of the application is an anti-C4d monoclonal antibody (mAb2) containing E430G and / or E345R substitutions for use in second-line immunotherapy in patients showing resistance to first-line immunotherapy.

Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

ANTIBODIES SPECIFIC FOR COMPLEMENT COMPONENT C4d AND USES THEREOF.
EP3191509A1
Complement c4d assay
WO2019234087A1

Patent Information

Abstract

Patent Citations

ANTIBODIES SPECIFIC FOR COMPLEMENT COMPONENT C4d AND USES THEREOF.

Complement c4d assay